Literature DB >> 13593495

Clinical application of a test for lupus globulin-nucleohistone interaction using fluorescent antibody.

G J FRIOU.   

Abstract

Entities:  

Keywords:  LUPUS ERYTHEMATOSUS, DISSEMINATED/immunology; NUCLEOPROTEINS/in blood; SERUM GLOBULIN

Mesh:

Substances:

Year:  1958        PMID: 13593495      PMCID: PMC2603909     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


× No keyword cloud information.
  7 in total

1.  Interaction of nuclei and globulin from lupus erythematosis serum demonstrated with fluorescent antibody.

Authors:  G J FRIOU; S C FINCH; K D DETRE
Journal:  J Immunol       Date:  1958-04       Impact factor: 5.422

2.  Complement fixation with cell nuclei and DNA in lupus erythematosus.

Authors:  W C ROBBINS; H R HOLMAN; H DEICHER; H G KUNKEL
Journal:  Proc Soc Exp Biol Med       Date:  1957-12

3.  Improved method for measuring lupus globulin-nucleoprotein interaction.

Authors:  G J FRIOU
Journal:  Proc Soc Exp Biol Med       Date:  1958-04

4.  [Absorption of L. E. factor by isolated cell nuclei].

Authors:  P MIESCHER; M FAUCONNET
Journal:  Experientia       Date:  1954-06-15

5.  Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases.

Authors:  A M HARVEY; L E SHULMAN; P A TUMULTY; C L CONLEY; E H SCHOENRICH
Journal:  Medicine (Baltimore)       Date:  1954-12       Impact factor: 1.889

6.  The incidence and etiologic background of chronic biologic false-positive reactions in serologic tests for syphilis.

Authors:  J E MOORE; C F MOHR
Journal:  Ann Intern Med       Date:  1952-12       Impact factor: 25.391

7.  Studies on nucleoproteins. I. Dissociation and reassociation of the deoxyribonucleohistone of calf thymus.

Authors:  C F CRAMPTON; R LIPSHITZ; E CHARGAFF
Journal:  J Biol Chem       Date:  1954-02       Impact factor: 5.486

  7 in total
  11 in total

Review 1.  Serologic laboratory findings in malignancy.

Authors:  Félix Fernández Madrid; Marie-Claire Maroun
Journal:  Rheum Dis Clin North Am       Date:  2011-11       Impact factor: 2.670

2.  Incidence of the anti-nuclear factor in human sera.

Authors:  W R ALEXANDER; J M BREMNER; J J DUTHIE
Journal:  Ann Rheum Dis       Date:  1960-12       Impact factor: 19.103

3.  Serum factors in lupus erythematosus and other diseases reacting with cell nuclei and nucleoprotein extracts: electrophoretic. ultracentrifugal and chromatographic studies.

Authors:  H C GOODMAN; J L FAHEY; R A MALMGREN
Journal:  J Clin Invest       Date:  1960-10       Impact factor: 14.808

4.  IMMUNOFLUORESCENT STAINING: THE FLUORESCENT ANTIBODY METHOD.

Authors:  E H Beutner
Journal:  Bacteriol Rev       Date:  1961-03

5.  DEMONSTRATION OF CIRCULATING ANTINUCLEAR GLOBULINS IN ULCERATIVE COLITIS.

Authors:  P Calabresi; W R Thayer; H M Spiro
Journal:  J Clin Invest       Date:  1961-12       Impact factor: 14.808

6.  Antinuclear antibody determination in a routine laboratory.

Authors:  T E Feltkamp
Journal:  Ann Rheum Dis       Date:  1996-10       Impact factor: 19.103

7.  [Studies on the importance of the fluorescence-antiglobulin test and the antiglobulin-consumption test for the demonstration of antinuclear serum factors].

Authors:  C Mueller-Eckhardt; K Schmidt; W Becker
Journal:  Blut       Date:  1968-07

8.  Multiple reticulohistiocytosis.

Authors:  E Swart; H T Calvert
Journal:  Proc R Soc Med       Date:  1969-10

9.  Autoantibodies: Focus on anti-DNA antibodies.

Authors:  Nina Almqvist; Thomas H Winkler; Inga-Lill Mårtensson
Journal:  Self Nonself       Date:  2011-01-01

Review 10.  New platform technology for comprehensive serological diagnostics of autoimmune diseases.

Authors:  Annika Willitzki; Rico Hiemann; Vanessa Peters; Ulrich Sack; Peter Schierack; Stefan Rödiger; Ursula Anderer; Karsten Conrad; Dimitrios P Bogdanos; Dirk Reinhold; Dirk Roggenbuck
Journal:  Clin Dev Immunol       Date:  2012-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.